Epidemiological Characteristics of Meningococcal Meningitis (2016 to 2018) Four Years after the Introduction of Serogroup A Meningococcal Conjugate Vaccine in Benin

被引:1
|
作者
Godjedo, Togbemabou Primous Martial [1 ,2 ]
Agbankpe, Alidehou Jerrold [3 ]
Paraiso, Moussiliou Noel [4 ]
Dougnon, Tamegnon Victorien [3 ]
Hidjo, Marie [3 ]
Baba-Moussa, Lamine [5 ]
Bankole, Honore [1 ,3 ]
机构
[1] Minist Publ Hlth, Epidmiol Surveillance Serv, Cotonou, Benin
[2] Minist Publ Hlth, Natl Hlth Lab, Cotonou, Benin
[3] Univ Abomey Calavi, Res Lab Appl Biol, Polytech Sch Abomey Calavi, Res Unit Appl Microbiol & Pharmacol Nat Subst, Cotonou, Benin
[4] Univ Abomey Calavi, Reg Inst Publ Hlth, Cotonou, Benin
[5] Univ Abomey Calavi, Lab Biol & Mol Typing Microbiol, Fac Sci & Technol, Cotonou, Benin
来源
ADVANCES IN PUBLIC HEALTH | 2020年 / 2020卷
关键词
BACTERIAL-MENINGITIS; COUNTRIES; BELT; SURVEILLANCE; AFRICA;
D O I
10.1155/2020/1932940
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study aims to study the epidemiological and geographic characteristics of the meningococcal serogroups four years after the introduction of serogroup A meningococcal conjugate vaccine.Methods. This is a prospective, descriptive, analytical study, and it took place from 2016 to 2018. Cerebrospinal fluid (CSF) samples were taken after the identification of meningitis cases. The samples, thus, taken were sent to the laboratory for culture and identification ofNeisseria meningitidisin accordance with WHO standards.Results. Eight hundred and ninety-nine bacterial strains were identified, of which 219 were strains ofNeisseria meningitidis. The majority ofN. meningitidis-positive samples were from male patients (59.8%) with a median age of 4 (IQR: 1-13). Four ofN. meningitidisserogroups were identified, namely, serogroups C (6.8%), W (19.6%), X (1.8%), and A (0.5%). Geographically, 92.7% of the identifiedN. meningitidisserogroups came from patients who lived in the northern region of the country. The departments most concerned were Alibori (N. meningitidisC (66.7%) andN. meningitidisW (20.9%)); Atacora (N. meningitidisW (41.9%),N. meningitidisX (75.0%), andN. meningitidisC (13.3%)); and Borgou (N. meningitidisW (23.3%)).Conclusion. The results of this study showed that there is an emergence of cases of meningococcal of serogroup C four years after the introduction of MenAfricVac in Benin. These results demonstrated the effectiveness of case-by-case surveillance in detecting small changes in the distribution of serogroups that could have important implications for public health strategies in the coming seasons.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017
    Fernandez, Katya
    Lingani, Clement
    Aderinola, Olaolu Moses
    Goumbi, Kadade
    Bicaba, Brice
    Edea, Zewdu Assefa
    Glele, Clement
    Sarkodie, Badu
    Tamekloe, Agbeko
    Ngomba, Armelle
    Djingarey, Mamoudou
    Bwaka, Ado
    Perea, William
    Ronveaux, Olivier
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S225 - S232
  • [2] Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
    Trotter, CL
    Andrews, NJ
    Kaczmarski, EB
    Miller, E
    Ramsay, ME
    LANCET, 2004, 364 (9431): : 365 - 367
  • [3] Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018
    Sidikou, Fati
    Potts, Caelin C.
    Zaneidou, Maman
    Mbaeyi, Sarah
    Kadade, Goumbi
    Paye, Marietou F.
    Ousmane, Sani
    Issaka, Bassira
    Chen, Alexander
    Chang, How-Yi
    Issifou, Djibo
    Lingani, Clement
    Sakande, Souleymane
    Bienvenu, Baruani
    Mahamane, Ali Elhadji
    Diallo, Alpha Oumar
    Moussa, Amadou
    Seidou, Issaka
    Abdou, Moussa
    Sidiki, Ali
    Garba, Omar
    Haladou, Sani
    Testa, Jean
    Nse, Ricardo Obama
    Mainassara, Halima Boubacar
    Wang, Xin
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S206 - S215
  • [5] Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018
    Bwaka, Ado
    Bita, Andre
    Lingani, Clement
    Fernandez, Katya
    Durupt, Antoine
    Mwenda, Jason M.
    Mihigo, Richard
    Djingarey, Mamoudou H.
    Ronveaux, Olivier
    Preziosi, Marie-Pierre
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S140 - S147
  • [6] Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
    Topaz, Nadav
    Kristiansen, Paul Arne
    Schmink, Susanna
    Congo-Ouedraogo, Malika
    Kambire, Dinanibe
    Mbaeyi, Sarah
    Paye, Marietou
    Sanou, Mahamoudou
    Sangare, Lassana
    Ouedraogo, Rasmata
    Wang, Xin
    MICROBIAL GENOMICS, 2020, 6 (12): : 1 - 9
  • [7] Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine
    Kristiansen, Paul A.
    Diomande, Fabien
    Wei, Stanley C.
    Ouedraogo, Rasmata
    Sangare, Lassana
    Sanou, Idrissa
    Kandolo, Denis
    Kabore, Pascal
    Clark, Thomas A.
    Ouedraogo, Abdoul-Salam
    Absatou, Ki Ba
    Ouedraogo, Charles D.
    Hassan-King, Musa
    Thomas, Jennifer Dolan
    Hatcher, Cynthia
    Djingarey, Mamoudou
    Messonnier, Nancy
    Preziosi, Marie-Pierre
    LaForce, Marc
    Caugant, Dominique A.
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (03) : 435 - 443
  • [8] Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys
    Mbaeyi, Sarah
    Sampo, Emmanuel
    Dinanibe, Kambire
    Yameogo, Issaka
    Congo-Ouedraogo, Malika
    Tamboura, Mamadou
    Sawadogo, Guetawende
    Ouattara, Kalifa
    Sanou, Mahamadou
    Kiemtore, Tanga
    Dioma, Gerard
    Sanon, Barnabe
    Somlare, Hermann
    Kyetega, Augustin
    Ba, Absatou Ky
    Ake, Flavien
    Tarbangdo, Felix
    Aboua, Frederic Acho
    Donnou, Yvette
    Kamate, Idrissa
    Patel, Jaymia C.
    Schrilink, Susanna
    Spiller, Michael W.
    Topaz, Nadav
    Novak, Ryan
    Wang, Xin
    Bicaba, Brice
    Sangare, Lassana
    Ouedraogo-Traore, Rosmata
    Kristiansen, Paul A.
    LANCET INFECTIOUS DISEASES, 2020, 20 (12): : 1418 - 1425
  • [9] Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
    Daugla, D. M.
    Gami, J. P.
    Gamougam, K.
    Naibei, N.
    Mbainadji, L.
    Narbe, M.
    Toralta, J.
    Kodbesse, B.
    Ngadoua, C.
    Coldiron, M. E.
    Fermon, F.
    Page, A-L
    Djingarey, M. H.
    Hugonnet, S.
    Harrison, O. B.
    Rebbetts, L. S.
    Tekletsion, Y.
    Watkins, E. R.
    Hill, D.
    Caugant, D. A.
    Chandramohan, D.
    Hassan-King, M.
    Manigart, O.
    Nascimento, M.
    Woukeu, A.
    Trotter, C.
    Stuart, J. M.
    Maiden, M. C. J.
    Greenwood, B. M.
    LANCET, 2014, 383 (9911): : 40 - 47
  • [10] Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
    Tauil, Marcia de Cantuaria
    Rodrigues de Carvalho, Cleidiane Santos
    Vieira, Ataiza Cesar
    Waldman, Eliseu Alves
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 18 (04): : 379 - 386